Effects of bromocriptine on pituitary tumour size.

Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36

Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32

Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. Br Med J (Clin Res Ed) (1983) 1.14

Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) (1984) 1.08

Prolactinoma: a question of rational treatment. Br Med J (Clin Res Ed) (1981) 0.96

Prolactinoma presenting with intermittent third nerve palsy. Br J Ophthalmol (1986) 0.93

Reduction in size of prolactin-secreting tumours in men treated with pergolide. Br Med J (Clin Res Ed) (1982) 0.83

Massive prolactinoma with galactorrhoea in a prepubertal boy. Postgrad Med J (1989) 0.79

Trends in the management of prolactinomas. Br Med J (1980) 0.75

Morphologic effects of bromocriptine on spontaneously occurring pituitary prolactin-cell hyperplasia in old Long-Evans rats. Am J Pathol (1986) 0.75

The 'Alice in Wonderland' experience. Ergot alkaloid therapy for prolactin-secreting pituitary tumors. West J Med (1983) 0.75

Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine. J Neurol Neurosurg Psychiatry (1985) 0.75

Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy. Postgrad Med J (1985) 0.75

A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol (1962) 18.80

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54

A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A (1971) 3.36

The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10

Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med (1977) 3.08

Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18

Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med (1978) 1.76

Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49

The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47

Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med (1977) 1.14

Variation in response to synthetic luteinizing hormone--releasing hormone (LH-RH) at different phases of the same menstrual cycle in normal women. J Obstet Gynaecol Br Commonw (1974) 1.12

Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet (1979) 1.08

Homologous radioimmunoassay for human prolactin. Int J Nucl Med Biol (1976) 1.06

Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours. Lancet (1977) 1.03

Assessment of thyroid hormone assays. J Clin Pathol (1976) 0.96

Regression of pituitary tumors, a possible effect of bromergocryptine. Am J Med (1979) 0.95

Ergot-induced inhibition of pituitary tumor growth in rats. Science (1972) 0.94

Bromocriptine in Nelson's syndrome and Cushing's disease. Lancet (1976) 0.94

Prolactin secreting tumors. Endocrine status before and after surgery in 33 women. J Clin Endocrinol Metab (1978) 0.90

Regression of pituitary prolactinoma after treatment with bromocriptine. Lancet (1979) 0.89

Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Am J Obstet Gynecol (1977) 0.88

The prolactinoma problem. N Engl J Med (1979) 0.84

Treatment of patients with prolactinomas. J Endocrinol Invest (1978) 0.84

Metrizamide cisternography in the evaluation of pituitary adenomas and the empty sella syndrome. J Neurosurg (1979) 0.83

Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine. Fertil Steril (1978) 0.82

Hyperprolactinemia. Morphologic and clinical considerations. Med Clin North Am (1978) 0.82

Computed tomographic diagnosis of suprasellar masses by intrathecal enhancement. Radiology (1977) 0.81

A reliable method for the specific determination of testosterone in plasma. Clin Chim Acta (1974) 0.80

Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome. J Endocrinol Invest (1978) 0.80

Direct antiproliferative effect of dopamine agonists on the anterior pituitary gland in organ culture. J Endocrinol (1978) 0.79

The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81

The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75

Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59

Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44

Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34

Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04

Effects of castration and of sexual hormones on the adrenals of male rats. J Physiol (1938) 3.95

The effects of testosterone and testosterone propionate on adult male rats (compared with those on female rats). Biochem J (1937) 3.42

Grades of hypothyroidism. Br Med J (1973) 3.30

Novel heterotrimeric kinesin-related protein purified from sea urchin eggs. Nature (1993) 3.22

Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18

The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10

Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84

The action of testosterone propionate on normal adult female rats. Biochem J (1937) 2.80

Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74

Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73

Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70

Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68

Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65

Somatomedin: proposed designation for sulphation factor. Nature (1972) 2.63

Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62

Correlation between sex hormones, thyroid hormones and desoxycorticosterone as judged by their effects on the weights of organs of gonadectomized rats. Biochem J (1941) 2.61

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61

"Spontaneous" transfer of stimulus control from tact to mand contingencies. Res Dev Disabil (1990) 2.59

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med (1994) 2.58

Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57

Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50

Computerised updating of clinical summaries: new opportunities for clinical practice and research? BMJ (1988) 2.49

Bromocriptine therapy in acromegaly. Lancet (1975) 2.42

Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32

Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21

A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature (1990) 2.20

Autoimmune thyroid disease: further developments in our understanding. Endocr Rev (1994) 2.19

Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet (1997) 2.11

A major outbreak of foodborne gastroenteritis among Air Force personnel during Operation Desert Storm. Mil Med (1993) 2.10

Postpartum thyroid dysfunction. Thyroid (1992) 2.03

Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00

Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99

Autoimmune thyroid disease: developments in our understanding. Endocr Rev (1984) 1.98

The manifold effects of prolonged administration of sex hormones to female rats. Biochem J (1939) 1.95

Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94

Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc (2000) 1.87

Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86

Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82

Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82

Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2000) 1.82

Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene (1998) 1.81

Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79

Insulin-like growth factors and their binding proteins. Physiol Rev (1990) 1.79

Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med (1991) 1.78

Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77

Prolonged administration of sex hormones to castrated rats. Biochem J (1939) 1.76

Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med (1987) 1.74

Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71

Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68

Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68

Dopamine agonists and pituitary tumor shrinkage. Endocr Rev (1992) 1.67

Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66

Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60

Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60

Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59

Dissociative disorders in psychiatric inpatients. Am J Psychiatry (1993) 1.59

A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58

Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56

Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52

Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51

A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51

Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50

Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) (1991) 1.50

Myopathy in acromegaly. Lancet (1970) 1.50

Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49

'Z-RNA'--a left-handed RNA double helix. Nature (1984) 1.48

Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48

The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47

The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Clin Endocrinol (Oxf) (2005) 1.47

Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology (2010) 1.46

Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology (1996) 1.45

Ovarian ultrasonography highlights precision of symptoms of ovulation as markers of ovulation. Br Med J (Clin Res Ed) (1986) 1.45

Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44

Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest (2000) 1.44

Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J (2001) 1.43

DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42

The evaluation of patients with a suspected pituitary microadenoma: computer tomography compared to magnetic resonance imaging. Clin Endocrinol (Oxf) (1992) 1.41

Allergy of the nervous system: a review. Ann Allergy (1976) 1.41

Hypothyroidism. Br Med J (1972) 1.41

Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade. Diabetes Care (1989) 1.41

Body composition derived from whole body counting of potassium in growth hormone-deficient adults: a possible low intracellular potassium concentration. J Clin Endocrinol Metab (1996) 1.40

Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39